Zafrens

Private

San Diego, CaliforniaHealthcare & Life Scienceshttps://www.zafrens.com/

Last Round

Series A

Feb 4, 2025

Total Funding Raised

$71.16M

Company Overview

Zafrens is a biotechnology company that develops an ultra-high throughput platform for single-cell analysis and drug discovery by integrating biology, chemistry, and engineering.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

single-cell analysisdrug discoverymicrofluidicshigh-throughput screeningbiotech platformsingle-cell sequencingfunctional genomicsproteomicstherapeutic lead identificationlab automationsingle-cell multi-omicsdrug discovery techbiotech R&Ddata as a serviceDaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Zafrens Comps

Public and private peers based on sector, stage, and business model.

Zafrens comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Zafrens Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Feb 4, 2025
Series A	Dec 11, 2023
Seed	Dec 30, 2021

View all Funding Rounds

Zafrens Investors

Notable investors and investment history

Zafrens investors
Investor	Rounds
Iaso Ventures	Series A
KOFA Healthcare	Series A
BlueYard Capital	Series A
FoundersX Ventures	Series A
Global Brain Corporation	Series A
Alix Ventures	Series A
Hawktail Management	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Feb 4, 2025
$31M round with participation from BlueYard Capital and others.

View all signals

Zafrens Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Zafrens Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Zafrens's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Diego, California

Employee Range30

Year Founded2021

Last FundingFeb 4, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.